Title : Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis.

Pub. Date : 2002 Mar 15

PMID : 11877267






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Reviparin administered twice daily plus vitamin K antagonist is more effective in inhibiting in vivo thrombin generation compared to intravenous unfractionated heparin plus vitamin K antagonist, and reviparin once daily produced significantly higher TFPI release and greater reduction in TAFI and fibrinogen levels. reviparin carboxypeptidase B2 Homo sapiens
2 Reviparin administered twice daily plus vitamin K antagonist is more effective in inhibiting in vivo thrombin generation compared to intravenous unfractionated heparin plus vitamin K antagonist, and reviparin once daily produced significantly higher TFPI release and greater reduction in TAFI and fibrinogen levels. reviparin carboxypeptidase B2 Homo sapiens